Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Selective inhibition of FLT3 by gilteritinib in relapsed ... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study
0
Authors
Alexander Perl
25 more
Alexander Perl
•
Jessica Altman
23 more
•
Mark Levis
Published
June 21, 2017
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Oncology
Topics
Physics
Internal Medicine
Medicine
Hematology
Surgery
Show all topics
DOI
10.1016/s1470-2045(17)30416-3
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Oncology
Topics
Physics
Internal Medicine
Medicine
Hematology
Surgery
Show all topics
DOI
10.1016/s1470-2045(17)30416-3
Other Formats
PDF
